Eikon Therapeutics Announces Seven Abstracts for ESMO Congress
The company announced the availability of seven abstracts for presentation at the European Society for Medical Oncology Congress.
Story updates
10:06:43 PM UTC
SquawkNews
Presentations to cover updates across Eikon’s clinical pipeline including:MILLBRAE, Calif., Oct. 18, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. NASDAQ:EIKN (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical…